Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antifungal management strategy in neutropenic oncohematologic patients using early voriconazole
2005-004973-55Phase 4Active
- Sponsor
- PETHEMA
- Start
- Jul 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of voriconazole in invasive mycoses, neutropenia and hematopoietic malignancies, sponsored by PETHEMA. Primary endpoint: Frequency of broad-spectrum antifungal use. Started Jul 2006; status: active.
02
Drugs
voriconazole
03
Conditions
invasive mycosesneutropeniahematopoietic malignancies
Beyond the preview
Go deeper on 2005-004973-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004973-55.